Lilly Plans to Invest Additional $450 million at Manufacturing Site in Research Triangle ParkPRNewsWire • 01/24/23
Eli Lilly shares slide as US regulator wants more data on its potential Alzheimer's treatmentProactive Investors • 01/20/23
In A Stunner, Eli Lilly Stock Falls After FDA Delivers A Blow To Its Alzheimer's DrugInvestors Business Daily • 01/20/23
US FDA accepts supplemental New Drug Application for Jardiance® for adults with chronic kidney diseasePRNewsWire • 01/20/23
U.S. Food and Drug Administration Issues Complete Response Letter for Accelerated Approval of DonanemabPRNewsWire • 01/19/23
Lilly Confirms Date and Conference Call for Fourth-Quarter 2022 Financial Results AnnouncementPRNewsWire • 01/19/23
Eli Lilly and Company (LLY) 41st Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/11/23